FDA Adverse Event
Malfunction
Summary report: N
0.8% SELECTOGEN
MDR report key: 1419156
·
Received July 21, 2009
Report
- Report Number
- 2250051-2009-00225
- Event Type
- Malfunction
- Date Received
- July 21, 2009
- Date of Event
- June 22, 2009
- Report Date
- July 21, 2009
- Manufacturer
- ORTHO-CLINICAL DIAGNOSTICS
- Product Code
- KSZ
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 1
ORTHO CLINICAL DIAGNOSTICS (OCD) PERFORMED RETAINED TESTING. SATISFACTORY RESULTS WERE OBSERVED.
Description of Event or Problem · 1
CUSTOMER REPORTED NO REACTIVITY WITH VS269 AND A PT WITH NO PREVIOUS TRANSFUSION HISTORY. IMMEDIATE SPIN CROSSMATCH IN TUBE WAS PERFORMED AND FOUR UNITS OF PACKED RED CELLS WERE TRANSFUSED. PT WAS LATER DETERMINED TO HAVE AN ANTI-E. OCD'S MEDICAL DIRECTOR HAS EVALUATED, THIS EVENT FOR SERIOUS INJURY. REVIEW OF THE CASE SHOWS THAT A WEAK ANTI-E WAS MISSED PRETRANSFUSION BY THE MANUAL GEL METHOD USING VS269. THIS EVENT HAS BEEN CLASSIFIED AS NOT A SERIOUS INJURY. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC. (B) (4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | 0.8% SELECTOGEN | REAGENT RED BLOOD CELLS | KSZ | ORTHO-CLINICAL DIAGNOSTICS | VS269 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |